Vibrants Total Tox Burden panel is an ideal starting point
Currently licensed GLP-1 receptor agonists in the UK include semaglutide (Ozempic for diabetes, Wegovy for weight management), liraglutide (Victoza for diabetes, Saxenda for weight management), dulaglutide (Trulicity), and exenatide (Byetta, Bydureon)
Hypoxia-inducible factor 1 (HIF-1) is a crucial transcription factor modulating the high energy requirements of immune cells to perform their effector functions in low-oxygen states (6770)
The company entered the GLP-1 space in 2023, following the FDAs approval of Zepbound, and has since made weight loss treatments one of its central offerings
[1] [7] It has not been approved by the MHRA, nor has it received a positive opinion from the EMA's Committee for Medicinal Products for Human Use (CHMP)